Nouscom will present at the 2nd European Oncology and Immono-Oncology Drug Discovery Symposium
Nouscom will present at the 2nd European Oncology and Immono-Oncology Drug Discovery Symposium on October 22, 2019 in Basel.
Nouscom will present at the 2nd European Oncology and Immono-Oncology Drug Discovery Symposium on October 22, 2019 in Basel.
Nouscom will present at the TMB & Neoantigen Congress from October 10-11, 2019 in London.
Nouscom is a private oncology company developing next generation immunotherapies, founded in 2015 by an experienced management team that has worked together for many years in previous successful enterprises. Nouscom’s proprietary technology platform harnesses the full power of the immune response by combining viral vectored genetic vaccines based on neoantigens with other immunomodulators.
